1-3 of 3
Michael J. Burns, BS
Close
Sort by
Journal Articles

Serum Concentrations of Vitamin B-12 and Alkaline Phosphatase in Newly Diagnosed Multiple Myeloma Patients.

Francesca Elice, MD, Maurizio Zangari, MD, Bart Barlogie, MD, Michael J. Burns, BS, Guido J. Tricot, MD, PhD, Sara Roberti, MD, Francesco Rodeghiero, MD, R. Jean Hine, PhD
Journal: Blood
Blood (2005) 106 (11): 5110.
https://doi.org/10.1182/blood.V106.11.5110.5110
Published: 2005
Journal Articles

The Anti-Myeloma Effect of Bortezomib Is Associated with Osteoblastic Activity.

Maurizio Zangari, MD, Kevin B. Najarian, MS, Dixie L. Esseltine, MD, Choon-Kee Lee, MD, Bart Barlogie, MD, PhD, Francesca Elice, MD, Michael J. Burns, BS, BA, Shmuel Yaccoby, PhD, Paul Richardson, MD, Pieter Sonneveld, MD
Journal: Blood
Blood (2005) 106 (11): 510.
https://doi.org/10.1182/blood.V106.11.510.510
Published: 2005
Journal Articles

Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.

Maurizio Zangari, MD, Bart Barlogie, MD, PhD, Michael J. Burns, BS, BA, Vanessa Bolejack, MPH, Klaus A. Hollmig, MD, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, Francesca Elice, MD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2552.
https://doi.org/10.1182/blood.V106.11.2552.2552
Published: 2005